Plasma reactor for Rhode Island
To support the marketing efforts of local companies based on composites and textiles, the 401 Tech Bridge Advanced Materials and Technology Center, administered by the University of Rhode Island (URI), is installing a Haydale HT200 plasma reactor.
The HT200 incorporates Haydale’s patented functionalization technologies specifically used by Graphene Composites, a nanomaterial engineering company, for its newly developed antiviral GC ink and other products.
GC Ink was independently tested by Brown University in Rhode Island to show effectiveness in neutralizing coronavirus and influenza viruses in less than a minute.
The patent-pending virucidal and germicidal ink is commercialized for a wide range of uses, including PPE, filtration solutions, and high contact surfaces.
The technology is highly effective because it has a double-acting mechanism: the negatively charged surface of graphene oxide captures the positively charged parts of water droplets, and the protein tips on coronavirus and silver nanoparticles release ions that oxidize the lipid membrane and coronavirus RNA protect. thereby neutralize.
“We are excited to partner with Haydale and work with Graphene Composites to bring the GC ink to market,” said Christian Cowan, Executive Director of Tech Bridge 401. “We will provide the Haydale equipment companies that conduct advanced materials research. “
“It is great to see Haydale’s patented functionalization process play such an important role in the adoption of nanotechnology in response to the increasing global focus on the need for viral efficacy,” added Keith Broadbent, CEO of Haydale.